Impact of Clinical Pharmacist-Provided Education onMedication Adherence Behaviourin ESRD Patients on Haemodialysis Role of clinical pharmacist on medication adherence
Iranian Journal of Pharmaceutical Sciences,
Vol. 5 No. 1 (2009),
15 January 2009
,
Page 21-30
https://doi.org/10.22037/ijps.v5.41144
Abstract
The aim of this research is to assess the impact of clinical pharmacist-provided education on medication adherence in haemodialysis patients. Ninety haemodialysispatients were randomized in to two groups. Brief medication questionnaire (BMQ),a tool for screening adherence was administered to both groups at the baseline toassess adherence to antihypertensives, vitamin D analogues, phosphate binders and folic acid in haemodialysis patients. The intervention group received education regarding their medications by a clinical pharmacist over seven weeks. The control group received standard care. At the end of eight weeks, BMQ was once again administered to patients of both groups. At the baseline, there was no significant difference in the mean BMQ regimen, belief, recall and the medication accesss creen scores of the control and intervention groups. At the end of the eighth week,there was a significant drop (p<0.05) in the mean scores of regimen, belief and recall screens of BMQ in the intervention group, indicating an improved level of medication adherence. For the control group, there was no significant drop in the mean BMQ screen scores. The reported level of non-adherence was the highest for phosphate binders. We conclude that clinical pharmacist-provided education was effective in improving adherence behaviour of haemodialysis patients.
- Clinical pharmacist education
- ESRD
- Hemodialysis
- Medicationadherence
How to Cite
References
[2]Manley HJ, Drayer DK, Muther RS. Medication-related problem type and appearance rate in ambulatory haemodialysis patients. BMC Nephrol 2003; 202: 4-10.
[3]Lundin AP. Causes of noncompliance in dialysis patients. Dialysis Transplant1995; 24: 174-6.
[4]Safdar N, Baakza H, Kumar H, Naqvi SA. Non-compliance to diet and fluid restrictions in haemodialysis patients. J Pak Med Assoc1995;45: 293-5.
[5]Kimmel PL, Peterson RA, Weihs KL, Boyle DH,Verme D, Umana WO, Veis JH, Alleyne S andCruz I. Behavioural compliance with dialysisprescription in haemodialysis patients.J Am SocNephrol 1995; 5: 1826-34.[6]Bame SI, Petersen N, Wry BP. Variation in haemodialysis patient compliance according to demographic characteristics. Soc Sci Med1993;37: 1035-43.
[7]Cleary DJ, Matzke GR, Alexander AC, Joy MS.Medication knowledge and compliance among patients receiving long-term dialysis. Am J Health Syst Pharm 1995; 52: 1895-900.
[8]Curtin RB, Svarstad BL, Keller TH.Haemodialysis patients' non-compliance with oral medications. ANNAJ 1999; 26: 307-16.
[9]Kutner NG. Improving compliance in dialysis patients: Does anything work? Semin Dial2001;14: 324-7.
[10]Batson H, Schwartz M. Techniques to improve compliance in hemo- and peritoneal dialysis patients. Nephrol News Issues1999; 58; 54-8.
[11]Skoutakis VA, Acchiardo SR, Martinez DR,Lorisch D, Wood GC. Role-effectiveness of the pharmacist in the treatment of haemodialysis patients. Am J Health Syst 1978; 35: 62-5.
[12]Matzke GR, St Peter WL, Comstock TJ, Foote EF.Nephrology pharmaceutical care preceptorship:Aprogrammatic and clinical outcomes assessment. Ann Pharmacother2000; 34: 593-9.
[14]Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med2006; 354: 997-9.
[15]Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: Atool for screening patient adherence and barriers to adherence. Patient Educ Couns1999; 37: 113-24.
[16]Osterberg L, Blaschke T. Adherence to medication.N Engl J Med 2005; 353: 487-97.
[17]Tomasello S, Dhupar S, Sherman RA. Phosphate binders, K/DOQI guidelines, and compliance:The unfortunate reality. Dialysis Transplant2004;33: 236-40.
[18]Hartman PE, Becker MH. Noncompliance with prescribed regimen among chronic haemodialysis patients: Amethod of prediction and education diagnosis. Dialysis Transplant1978; 7: 978-86.
[19]Cummings KM, Becker MH, Kirscht JP, Levin NW. Psychological factors affecting adherence to medical regiments in a group of haemodialysis patients. Med Care1982; 20: 567-80.
[20]Makaryus AN, Friedman EA. Patients'understanding of their treatment plans and diagnosis at discharge. Mayo Clin Croc 2005;80: 991-4.
[21]Rosner F. Patient noncompliance: Causes and solutions. Mount Sinai J Med2006; 73: 553-9.
[22]Meichenbaum D, Turk DC. Facilitating treatment adherence: Apractitioner's guidebook.New York:Plenum Press; 1987.
[23]Curtin RB, Svarstad BL, Andress D, Keller T,Sacksteder P. Differences in older versus younger haemodialysis patients' noncompliance with oral medications. Geriatr Nephrol Urol 1997; 7: 35-44.
[24]Krueger KP, Felkey BG, Berger BA. Improving adherence and persistence: Areview and assessment of interventions and description of steps toward a national adherence initiative. J A Pharm Assoc 2003; 43: 668-9.
- Abstract Viewed: 88 times
- IJPS_Volume 5_Issue 1_Pages 21-30 Downloaded: 20 times